NEW YORK – British molecular assay startup Biofidelity announced today that it has received a £500,000 ($610,851) grant from Innovate UK to further develop its chemistry platform for detecting gene targets.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.